glp 1 agonist breastfeeding GLP-1 and – what you need to know and why GLP-1 Medications and Breastfeeding
Description
Were learning things we couldnt have learned before, Hardaway said

Were going to have lots of new opportunities for pharmacotherapies in our hands in the next couple of years, Davies said
A.CarrM

3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%

Studies suggest these effects stem from weight loss, improved insulin sensitivity, and direct actions on metabolic pathways that regulate lipid production
Muller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, and Tschop MH
